ARCHIVES

DCT Board Approves Recompetition Of Drug Development Contracts

This article is from The Cancer Letter archive.

Vol. 19 No. 26 | June 25, 1993

Download PDF Visit The Full Archive

Related Articles

NCI Anticipates 60% Decline In Number Of New Trials By Cooperative Groups.

January 12, 2007

NIH reauthorization Bill slates For House Vote;

May 28, 1993

Obama Picks Hamburg for FDA Commissioner

March 20, 2009

Laertrile Clinical Study Provides Solid Evidence: It Is Useless

May 8, 1981

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006

In Brief: Durant New President Of AACI, Ultmann Named President-Elect; Farber Center Gets New Name

February 4, 1983